Jefferies Group LLC Inovio Pharmaceuticals, Inc. Transaction History

Jefferies Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $23,771 - $39,952	14,320 Added 111.28%	27,188 $0
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $18,529 - $51,214	12,868 New	12,868 $0
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $18,717 - $27,982	-3,751 Closed	0 $0
Q3 2021 Sep 21, 2023	SELL	$7.16 - $9.69 $3.56 Million - $4.81 Million	-496,741 Reduced 99.25%	3,751 $26,000
Q3 2021 Nov 15, 2021	SELL	$7.16 - $9.69 $3.56 Million - $4.81 Million	-496,741 Reduced 99.25%	3,751 $27,000
Q4 2020 Sep 21, 2023	BUY	$8.5 - $12.85 $4.02 Million - $6.08 Million	473,304 Added 1740.86%	500,492 $4.43 Million
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $4.25 Million - $6.43 Million	500,492 New	500,492 $4.43 Million
Q2 2019 Aug 14, 2019	SELL	$2.29 - $4.1 $65,033 - $116,435	-28,399 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.34 - $5.1 $94,852 - $144,834	28,399 New	28,399 $106,000
Q4 2018 Feb 14, 2019	SELL	$3.89 - $6.11 $121,955 - $191,554	-31,351 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.92 - $5.58 $122,895 - $174,938	31,351 New	31,351 $174,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $496M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.